# Stacie Dusetzina
Najpopularniejsze odcinki podcastów
Zaktualizowano:
Top podcast episodes featuring stacie dusetzina.
Medicare Advantage Supplemental Benefits: What We've Learned
This episode is brought to you by Semafor Healthcare.
Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and…
372: A pharma C-suite shakeup and Trump's deal with Pfizer
How will we look back on Emma Walmsley's tenure as GSK's CEO? Why did one of the FDA's top drug officials call out an obscure lupus drug on LinkedIn? And will we ever stop talking about the pharma patent cliff?Adam is out this week, so Allison and Elaine dive into the latest news, starting with ano…
Will Trump’s Prescription Drug Deals Really Lower Prices?
Facing unprecedented pressure from the Trump administration, some of the world’s top drugmakers promise to cut prices. But experts say the savings might not be what they seem.
Guests:
Michael Cannon, Director of Health Policy Studies, Cato Institute
Stacie Dusetzina, Professor of Health Policy, Va…
Pharmaceutical Tariffs Explained: The Will-They-Won’t-They Story of 2025
This episode is brought to you by Semafor Healthcare.
Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and…
The potential impact of lowering the cost of weight loss drugs
Millions of Americans will soon have direct access to popular weight-loss drugs at far lower prices than they pay now. That’s due to a deal announced between President Trump and pharmaceutical giants Eli Lilly and Novo Nordisk. William Brangham discussed the deal and its potential impact with Staci…
Rising Costs, Fewer Choices: What’s Up with Medicare Drug Plans?
Facing mounting financial pressures, insurance companies are changing the prescription drug coverage available to many consumers in Medicare Part D.
Guests:
Stacie Dusetzina, Professor of Health Policy, Vanderbilt University
Steven Hadfield, Medicare beneficiary
Mark Newsom, Managing Director, Ava…
BEST OF: The Great Health Care Vision Board (Stacie Dusetzina)
This episode is brought to you by Semafor Healthcare.
Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and…
NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss.
Stacie Dusetzina is a professor of health policy and of cancer research at the Vanderbilt University School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina. Access to GLP-1s for Medicare Beneficiaries — A Bridge to Nowhere? N Engl J M…
AH110 - Inside the 2026 U.S. Medicine Use Trends Report with Michael Kleinrock
What happens when two consecutive years of double-digit drug spending growth collide with a wave of pricing legislation, executive orders, and policy turbulence? On the latest episode of Astonishing Healthcare, host Justin Venneri welcomes Michael Kleinrock, Director of Research Development at the …
WYSZUKIWARKA PODCASTÓW
Możesz skorzystać z naszej strony internetowej, aby wyszukiwać podcasty3,830,049i odcinki196,567,656według osób, miejsc lub tematów.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
EDYTUJ
Dziękujemy za pomoc w aktualizowaniu podcastowej bazy danych.
